van Houte Hans
5 of 18 shown
The 5 most recent of 18 visible filings, newest first.
- Nurix Therapeutics, Inc. Chief financial officer$23,800Open-market sale
- Nurix Therapeutics, Inc. Chief financial officer$50,762Open-market sale
- Nurix Therapeutics, Inc. Chief financial officer3,573 sharesOption exercise
- Nurix Therapeutics, Inc. Chief financial officer2,859 sharesOption exercise
- Nurix Therapeutics, Inc. Chief financial officer3,750 sharesOption exercise